Hikma Pharmaceuticals PLC cancelled the acquisition of GlaxoSmithKline S.A.E.
Hikma Pharmaceuticals PLC (LSE:HIK) cancelled the acquisition of GlaxoSmithKline S.A.E (CASE:BIOC) on March 11, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.26 EGP | -2.55% | -2.59% | -20.51% |
1st Jan change | Capi. | |
---|---|---|
-20.51% | 49.58M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |